23,036,271
Vote Records
25,695
Companies
11,771
Funds
3,902
Managers

Home › Companies › MEDPACE HOLDINGS INC. › 2023-2024

MEDPACE HOLDINGS INC. 2023-2024 Proxy Voting Records

Download data (CSV): ballot items · votes by manager · column guide.

Compiled from SEC Form N-PX filings and MEDPACE HOLDINGS INC.’s Form 8-K, filed May 21, 2024 (Item 5.07 on EDGAR). Page generated November 20, 2026.

  • 5Ballot items
  • 532Asset managers, any item
  • 3,281Fund votes
  • May 17, 2024Meeting date

Results at a glance

Meeting of May 17, 2024: 5 items on MEDPACE HOLDINGS INC.’s Form 8-K, filed May 21, 2024: 2 elected · 3 approved.

Dissent

Significant dissent: 2 directors (39.0%, 30.5% against).

Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore MEDPACE HOLDINGS INC. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by MEDPACE HOLDINGS INC.

These tallies are MEDPACE HOLDINGS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 21, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

MEDPACE HOLDINGS INC. — official shareholder meeting results, meeting held May 17, 2024
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Fred B. Davenport, Jr. 16,532,146---- 10,556,0961,646,311 61%Elected—
Elect Director: Cornelius P. McCarthy III 18,826,983---- 8,261,2591,646,311 70%Elected—
2. Ratification of Appointment of Independent Registered Public Accounting Firm The appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024 27,926,739800,7977,017 ---- 97%Approved—
3. Advisory Vote on the Compensation of our Named Executive Officers The proposal to approve, on an advisory basis, the compensation of the Company's Named Executive Officers 26,373,187701,63013,425 --1,646,311 97%Approved—
4. Amendment to the Company's Amended and Restated Certificate of Incorporation to begin phasing out the Company's classified Board of Directors so that directors up for election at and after the 2025 Annual Meeting of Stockholders will be elected annually 27,081,9764,4071,859 --1,646,311 99.9%Approved—

Source: MEDPACE HOLDINGS INC., Form 8-K, filed with the SEC on May 21, 2024 — read the filing on EDGAR.

How asset managers voted at the MEDPACE HOLDINGS INC. 2023-2024 meeting

532 asset managers disclosed a vote on at least one MEDPACE HOLDINGS INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.

Elect Director: Fred B. Davenport, Jr.

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 5 wordings of this item as funds reported it.

61% Majority: yes · of votes cast

FOR 61%WITHHELD
FOR: 16,532,146WITHHELD: 10,556,096
Details: description as filed, official tally, votes by 129 asset managers

Description as filed by funds: Election of Directors: Fred B. Davenport, Jr.

MEDPACE HOLDINGS INC.’s own tally for this item (“Elect Director: Fred B. Davenport, Jr.”): 16,532,146 for, 10,556,096 withheld, per its Form 8-K filed May 21, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 1 — Election of Directors The following nominees were elected to the Company's Board of Directors to serve as Class II Directors until the Company's 2027 Annual Meeting of Stockholders based upon the following votes:”
Support: 61% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 129 asset managers below reported 6,232,430 for, 3,123 against, 3,694,400 withheld, 369,191 abstained.

FORWITHHOLD
FOR: 6,232,430AGAINST: 3,123ABSTAIN: 369,191WITHHOLD: 3,694,400
Largest asset managers voting on “Election of Directors: Fred B. Davenport, Jr.” at MEDPACE HOLDINGS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard2,815,1570 051,818For
BlackRock00 01,472,113Withhold
Fidelity717,7250 028,394For
Invesco702,4790 00For
WASATCH FUNDS TRUST513,8140 00For
Capitol Series Trust00 0298,993Withhold
Dimensional00 0237,879Withhold
Charles Schwab201,7300 00For
T. Rowe Price00 0194,643Withhold
Goldman Sachs1,5790 0151,358Withhold
State Street660 0147,753Withhold
John Hancock104,9030 28,0120Mixed
Prudential/PGIM132,1630 00For
OLD WESTBURY FUNDS INC00 0120,457Withhold
CARILLON SERIES TRUST8,7830 111,6350Mixed
First Trust00 0119,143Withhold
BOSTON TRUST WALDEN FUNDS00 0107,780Withhold
Putnam107,1910 00For
Legg Mason100,1160 03,458For
TIAA99,1260 00For
Loomis Sayles00 92,4580Abstain
Columbia Threadneedle88,8360 00For
JPMorgan87,7610 00For
PROFESSIONALLY MANAGED PORTFOLIOS82,3040 00For
Manager Directed Portfolios59,2960 00For

Showing the 25 largest of 129 asset managers. All 129 are in the interactive database (link above).

Elect Director: Cornelius P. McCarthy III

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 6 wordings of this item as funds reported it.

70% Majority: yes · of votes cast

FOR 70%WITHHELD
FOR: 18,826,983WITHHELD: 8,261,259
Details: description as filed, official tally, votes by 128 asset managers

Description as filed by funds: Election of Directors: Cornelius P. McCarthy III

MEDPACE HOLDINGS INC.’s own tally for this item (“Elect Director: Cornelius P. McCarthy III”): 18,826,983 for, 8,261,259 withheld, per its Form 8-K filed May 21, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 1 — Election of Directors The following nominees were elected to the Company's Board of Directors to serve as Class II Directors until the Company's 2027 Annual Meeting of Stockholders based upon the following votes:”
Support: 70% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 128 asset managers below reported 7,776,157 for, 3,123 against, 2,162,503 withheld, 355,561 abstained.

FORWITHHOLD
FOR: 7,776,157AGAINST: 3,123ABSTAIN: 355,561WITHHOLD: 2,162,503
Largest asset managers voting on “Election of Directors: Cornelius P. McCarthy III” at MEDPACE HOLDINGS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard2,815,1570 051,818For
BlackRock1,472,1130 00For
Fidelity734,5190 011,600For
Invesco702,4790 00For
WASATCH FUNDS TRUST513,8140 00For
Capitol Series Trust00 0298,993Withhold
Dimensional00 0237,879Withhold
Charles Schwab201,7300 00For
T. Rowe Price00 0194,643Withhold
Goldman Sachs1,5790 0151,358Withhold
State Street660 0147,753Withhold
John Hancock104,9030 28,0120Mixed
Prudential/PGIM132,1630 00For
OLD WESTBURY FUNDS INC00 0120,457Withhold
CARILLON SERIES TRUST8,7830 111,6350Mixed
First Trust00 0119,143Withhold
BOSTON TRUST WALDEN FUNDS00 0107,780Withhold
Putnam107,1910 00For
Legg Mason100,1160 03,458For
TIAA99,1260 00For
Loomis Sayles00 92,4580Abstain
Columbia Threadneedle88,8360 00For
JPMorgan87,7610 00For
PROFESSIONALLY MANAGED PORTFOLIOS82,3040 00For
Manager Directed Portfolios59,2960 00For

Showing the 25 largest of 128 asset managers. All 128 are in the interactive database (link above).

Amendment to the Company's Amended and Restated Certificate of Incorporation to begin phasing out the Company's…

Official resultCORPORATE GOVERNANCEReported outcome: Approved

Combines 4 wordings of this item as funds reported it.

99.9% Approved · of votes cast

FOR 99.9%
FOR: 27,081,976AGAINST: 4,407
Details: description as filed, official tally, votes by 134 asset managers

Description as filed by funds: To approve an amendment to the Company's Amended and Restated Certificate of Incorporation to begin phasing out the Company's classified Board of Directors so that directors up for election at and after the 2025 Annual Meeting of Stockholders will be elected annually.

MEDPACE HOLDINGS INC.’s own tally for this item (“4. Amendment to the Company's Amended and Restated Certificate of Incorporation to begin phasing out the Company's classified Board of Directors so that directors up for election at and after the 2025 Annual Meeting of S”): 27,081,976 for, 4,407 against — passed, per its Form 8-K filed May 21, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The proposal to amend the Company's Amended and Restated Certificate of Incorporation to begin phasing out the Company's classified Board of Directors so that directors up for election at and after the 2025 Annual Meeting of Stockholders will be elected annually was approved based upon the followin…”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 134 asset managers below reported 10,026,401 for, 1,511 against.

FOR
FOR: 10,026,401AGAINST: 1,511
Largest asset managers voting on “To approve an amendment to the Company's Amended and Restated Certificate of Incorporation to begin phasing ou” at MEDPACE HOLDINGS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard2,866,9750 00For
BlackRock1,472,1130 00For
Fidelity746,1190 00For
Invesco702,4790 00For
WASATCH FUNDS TRUST513,8140 00For
Dimensional237,8790 00For
Charles Schwab201,7300 00For
T. Rowe Price194,6430 00For
Goldman Sachs152,9370 00For
State Street147,8190 00For
John Hancock132,9150 00For
Prudential/PGIM132,1630 00For
OLD WESTBURY FUNDS INC120,4570 00For
CARILLON SERIES TRUST120,4180 00For
First Trust119,1430 00For
BOSTON TRUST WALDEN FUNDS107,7800 00For
Putnam107,1910 00For
Legg Mason103,5740 00For
TIAA99,1260 00For
Loomis Sayles92,4580 00For
Columbia Threadneedle88,8360 00For
JPMorgan87,7610 00For
PROFESSIONALLY MANAGED PORTFOLIOS82,3040 00For
Manager Directed Portfolios59,2960 00For
Jackson National58,4980 00For

Showing the 25 largest of 134 asset managers. All 134 are in the interactive database (link above).

Advisory Vote on the Compensation of our Named Executive Officers The proposal to approve, on an advisory basis, the…

Official resultFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 5 wordings of this item as funds reported it.

97% Approved · of votes cast

FOR 97%
FOR: 26,373,187AGAINST: 701,630
Details: description as filed, official tally, votes by 502 asset managers

Description as filed by funds: To approve, on an advisory basis, the compensation of our named executive officers as disclosed in the proxy statement for the 2024 Annual Meeting.

MEDPACE HOLDINGS INC.’s own tally for this item (“3. Advisory Vote on the Compensation of our Named Executive Officers The proposal to approve, on an advisory basis, the compensation of the Company's Named Executive Officers”): 26,373,187 for, 701,630 against — passed, per its Form 8-K filed May 21, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 3 — Advisory Vote on the Compensation of our Named Executive Officers The proposal to approve, on an advisory basis, the compensation of the Company's Named Executive Officers was approved based upon the following votes:”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of MEDPACE HOLDINGS INC.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Advisory Vote to Ratify Named Executive Officers' Compensation” (24 managers, Fund and manager reports combined; may count the same shares twice; no share total shown); “Section 14a Executive Compensation” (6 managers, Fund and manager reports combined; may count the same shares twice; no share total shown); “To approve, on an advisory basis, the H of our named executive officers as disclosed in the proxy statement for the 2024 Annual Meeting.” (2 managers, 15,420 for).

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 132 asset managers voting on “To approve, on an advisory basis, the compensation of our named executive officers as disclosed in the proxy s” at MEDPACE HOLDINGS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard2,866,9750 00For
BlackRock1,472,1130 00For
Fidelity746,1190 00For
Invesco702,4790 00For
WASATCH FUNDS TRUST513,8140 00For
Dimensional237,8790 00For
Charles Schwab201,7300 00For
T. Rowe Price194,6430 00For
Goldman Sachs152,9370 00For
State Street147,8190 00For
John Hancock132,9150 00For
Prudential/PGIM132,1630 00For
OLD WESTBURY FUNDS INC120,4570 00For
CARILLON SERIES TRUST120,4180 00For
First Trust119,1430 00For
BOSTON TRUST WALDEN FUNDS107,7800 00For
Putnam107,1910 00For
Legg Mason103,5740 00For
TIAA99,1260 00For
Loomis Sayles92,4580 00For
Columbia Threadneedle88,8360 00For
JPMorgan87,7610 00For
PROFESSIONALLY MANAGED PORTFOLIOS82,3040 00For
Manager Directed Portfolios59,2960 00For
Jackson National58,4980 00For

Fund voting reports, all 132 managers: 10,005,180 for, 1,247 against, 5,608 abstained. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 398 asset managers voting on “To approve, on an advisory basis, the compensation of our named executive officers as disclosed in the proxy s” at MEDPACE HOLDINGS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
OAK RIDGE INVESTMENTS LLC10,000,0000 00For
BlackRock839,8440 00For
Invesco773,6340 00For
WASATCH ADVISORS LP696,2030 00For
State Street629,9550 00For
GEODE CAPITAL MANAGEMENT, LLC520,1550 00For
Man Group plc0514,210 00Against
RIVERBRIDGE PARTNERS LLC484,1560 00For
BESSEMER TRUST Co NATIONAL ASSOCIATION457,2400 00For
Epoch Investment Partners, Inc.380,0420 00For
Bessemer Trust CO of Delaware, N.A.319,2800 00For
Wellington316,2950 00For
FULLER & THALER ASSET MANAGEMENT, INC.313,4690 00For
BESSEMER TRUST Co OF FLORIDA312,8350 00For
DE Shaw279,4260 00For
BESSEMER TRUST CO276,2640 00For
Bessemer Trust Co of California, N.A.266,5530 00For
Bessemer Trust Co of Nevada, National Association266,1160 00For
T. Rowe Price264,9760 00For
Clearbridge Investments, LLC244,0870 00For
Fidelity215,4100 00For
Northern Trust207,3540 00For
Charles Schwab203,5740 00For
EAGLE ASSET MANAGEMENT INC201,1730 00For
LOS ANGELES CAPITAL MANAGEMENT LLC188,6410 00For

Institutional-manager reports, all 398 managers: 24,376,572 for, 950,034 against, 697 not voted, 519 unknown. Showing the 25 largest; every one is in the interactive database (link above).

Ratification of Appointment of Independent Registered Public Accounting Firm The appointment of Deloitte & Touche LLP…

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 6 wordings of this item as funds reported it.

97% Approved · of votes cast

FOR 97%
FOR: 27,926,739AGAINST: 800,797
Details: description as filed, official tally, votes by 138 asset managers

Description as filed by funds: To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024.

MEDPACE HOLDINGS INC.’s own tally for this item (“2. Ratification of Appointment of Independent Registered Public Accounting Firm The appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December ”): 27,926,739 for, 800,797 against — passed, per its Form 8-K filed May 21, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 2 — Ratification of Appointment of Independent Registered Public Accounting Firm The appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024 was ratified based upon the following votes:”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 138 asset managers below reported 10,340,129 for, 18,542 against, 5,608 abstained.

FOR
FOR: 10,340,129AGAINST: 18,542ABSTAIN: 5,608
Largest asset managers voting on “To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for th” at MEDPACE HOLDINGS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard2,866,9750 00For
BlackRock1,472,1130 00For
Fidelity746,1190 00For
Invesco702,4790 00For
WASATCH FUNDS TRUST513,8140 00For
Capitol Series Trust298,9930 00For
Dimensional237,8790 00For
Charles Schwab201,7300 00For
T. Rowe Price194,6430 00For
Goldman Sachs152,9370 00For
State Street147,80118 00For
John Hancock132,9150 00For
Prudential/PGIM132,1630 00For
OLD WESTBURY FUNDS INC120,4570 00For
CARILLON SERIES TRUST120,4180 00For
First Trust119,1430 00For
BOSTON TRUST WALDEN FUNDS107,7800 00For
Putnam107,1910 00For
Legg Mason103,5740 00For
TIAA99,1260 00For
Loomis Sayles92,4580 00For
Columbia Threadneedle88,8360 00For
JPMorgan87,7610 00For
PROFESSIONALLY MANAGED PORTFOLIOS82,3040 00For
Manager Directed Portfolios59,2960 00For

Showing the 25 largest of 138 asset managers. All 138 are in the interactive database (link above).

Largest MEDPACE HOLDINGS INC. shareholders voting in 2023-2024

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 30,983,185 shares outstanding at the time of that meeting.

Fund voting reports: top MEDPACE HOLDINGS INC. shareholders by shares voted on “To ratify the appointment of Deloitte & Touche LLP as our independent registered public…”, 2023-2024
#Asset manager % of shares outstanding
1Vanguard 9.25%
2BlackRock 4.75%
3Fidelity 2.41%
4Invesco 2.27%
5WASATCH FUNDS TRUST 1.66%
6Capitol Series Trust 0.97%
7Dimensional 0.77%
8Charles Schwab 0.65%
9T. Rowe Price 0.63%
10Goldman Sachs 0.49%
Institutional-manager reports: top MEDPACE HOLDINGS INC. shareholders by shares voted on “To approve, on an advisory basis, the compensation of our named executive officers as disclosed…”, 2023-2024
#Asset manager % of shares outstanding
1OAK RIDGE INVESTMENTS LLC 32.28%
2BlackRock 2.71%
3Invesco 2.50%
4WASATCH ADVISORS LP 2.25%
5State Street 2.03%
6GEODE CAPITAL MANAGEMENT, LLC 1.68%
7Man Group plc 1.66%
8RIVERBRIDGE PARTNERS LLC 1.56%
9BESSEMER TRUST Co NATIONAL ASSOCIATION 1.48%
10Epoch Investment Partners, Inc. 1.23%

Reported MEDPACE HOLDINGS INC. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.

MEDPACE HOLDINGS INC. holdings and ownership disclosed for the 2023-2024 proxy season, with each row’s source and date
HolderShares % outstandingSource, as of
August J. Troendle6,046,852 19.52%Proxy statement (DEF 14A), proxy filed April 3, 2024
Medpace Investors, LLC4,733,019 15.28%Proxy statement (DEF 14A), proxy filed April 3, 2024
BlackRock2,357,123 7.61%Form 13F, quarter ended March 31, 2024
Vanguard Group2,282,972 7.37%Form 13F, quarter ended March 31, 2024
Wasatch Advisors LP1,186,181 3.83%Proxy statement (DEF 14A), proxy filed April 3, 2024
Invesco815,801 2.63%Form 13F, quarter ended March 31, 2024
State Street696,959 2.25%Form 13F, quarter ended March 31, 2024
Geode Capital532,749 1.72%Form 13F, quarter ended March 31, 2024
Morgan Stanley510,923 1.65%Form 13F, quarter ended March 31, 2024
D.E. Shaw372,079 1.20%Form 13F, quarter ended March 31, 2024

Percentages above are of 30,983,185 shares outstanding, as reported by MEDPACE HOLDINGS INC. on its Form 10-Q dated March 31, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this meeting

At MEDPACE HOLDINGS INC.'s shareholder meeting held May 17, 2024, in the 2023-2024 proxy season, 532 asset managers reported votes on at least one of its 5 ballot items in their SEC Form N-PX filings, covering 3,281 separate fund positions. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation of our named executive officers as disclosed… — MEDPACE HOLDINGS INC.'s filing reports the proposal as approved, with 97% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: MEDPACE HOLDINGS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 21, 2024.

Related

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from MEDPACE HOLDINGS INC.’s 10-Q dated March 31, 2024. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.

MEDPACE HOLDINGS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.

Cite this page

Proxy Votes Now, “MEDPACE HOLDINGS (MEDP) 2024 Annual Meeting: Shareholder Vote Results”, https://proxyvotesnow.com/company/medpace-holdings-inc/2024 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.